The global market for Diagnostic Radiopharmaceuticals & Contrast Media was valued at US$ 10410 million in the year 2024 and is projected to reach a revised size of US$ 12900 million by 2031, growing at a CAGR of 3.2% during the forecast period.

Diagnostic Radiopharmaceuticals & Contrast Media Market

North American market for Diagnostic Radiopharmaceuticals & Contrast Media is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Diagnostic Radiopharmaceuticals & Contrast Media is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global manufacturers of Diagnostic Radiopharmaceuticals & Contrast Media include Amag Pharmaceuticals, Bayer Healthcare, Bracco Imaging, Daiichi Sankyo, GE Healthcare, Guerbet, Lantheus, Mallinckrodt, Medtronic, Nordion, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Diagnostic Radiopharmaceuticals & Contrast Media, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Diagnostic Radiopharmaceuticals & Contrast Media.

The Diagnostic Radiopharmaceuticals & Contrast Media market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Diagnostic Radiopharmaceuticals & Contrast Media market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Diagnostic Radiopharmaceuticals & Contrast Media manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Diagnostic Radiopharmaceuticals & Contrast Media Market Report

Report Metric	Details
Report Name	Diagnostic Radiopharmaceuticals & Contrast Media Market
Accounted market size in year	US$ 10410 million
Forecasted market size in 2031	US$ 12900 million
CAGR	3.2%
Base Year	year
Forecasted years	2025 - 2031
Segment by Type	Radiopharmaceuticals Contrast Media
Segment by Application	Hospital Clinic Other
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	Amag Pharmaceuticals, Bayer Healthcare, Bracco Imaging, Daiichi Sankyo, GE Healthcare, Guerbet, Lantheus, Mallinckrodt, Medtronic, Nordion
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Diagnostic Radiopharmaceuticals & Contrast Media manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Diagnostic Radiopharmaceuticals & Contrast Media in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

FAQ for this report

How fast is Diagnostic Radiopharmaceuticals & Contrast Media Market growing?

Ans: The Diagnostic Radiopharmaceuticals & Contrast Media Market witnessing a CAGR of 3.2% during the forecast period 2025-2031.

What is the Diagnostic Radiopharmaceuticals & Contrast Media Market size in 2031?

Ans: The Diagnostic Radiopharmaceuticals & Contrast Media Market size in 2031 will be US$ 12900 million.

Who are the main players in the Diagnostic Radiopharmaceuticals & Contrast Media Market report?

Ans: The main players in the Diagnostic Radiopharmaceuticals & Contrast Media Market are Amag Pharmaceuticals, Bayer Healthcare, Bracco Imaging, Daiichi Sankyo, GE Healthcare, Guerbet, Lantheus, Mallinckrodt, Medtronic, Nordion

What are the Application segmentation covered in the Diagnostic Radiopharmaceuticals & Contrast Media Market report?

Ans: The Applications covered in the Diagnostic Radiopharmaceuticals & Contrast Media Market report are Hospital, Clinic, Other

What are the Type segmentation covered in the Diagnostic Radiopharmaceuticals & Contrast Media Market report?

Ans: The Types covered in the Diagnostic Radiopharmaceuticals & Contrast Media Market report are Radiopharmaceuticals, Contrast Media

1 Diagnostic Radiopharmaceuticals & Contrast Media Market Overview

1.1 Product Definition

1.2 Diagnostic Radiopharmaceuticals & Contrast Media by Type

1.2.1 Global Diagnostic Radiopharmaceuticals & Contrast Media Market Value Comparison by Type (2024 VS 2031)

1.2.2 Radiopharmaceuticals

1.2.3 Contrast Media

1.3 Diagnostic Radiopharmaceuticals & Contrast Media by Application

1.3.1 Global Diagnostic Radiopharmaceuticals & Contrast Media Market Value by Application (2024 VS 2031)

1.3.2 Hospital

1.3.3 Clinic

1.3.4 Other

1.4 Global Diagnostic Radiopharmaceuticals & Contrast Media Market Size Estimates and Forecasts

1.4.1 Global Diagnostic Radiopharmaceuticals & Contrast Media Revenue 2020-2031

1.4.2 Global Diagnostic Radiopharmaceuticals & Contrast Media Sales 2020-2031

1.4.3 Global Diagnostic Radiopharmaceuticals & Contrast Media Market Average Price (2020-2031)

1.5 Assumptions and Limitations

2 Diagnostic Radiopharmaceuticals & Contrast Media Market Competition by Manufacturers

2.1 Global Diagnostic Radiopharmaceuticals & Contrast Media Sales Market Share by Manufacturers (2020-2025)

2.2 Global Diagnostic Radiopharmaceuticals & Contrast Media Revenue Market Share by Manufacturers (2020-2025)

2.3 Global Diagnostic Radiopharmaceuticals & Contrast Media Average Price by Manufacturers (2020-2025)

2.4 Global Key Players of Diagnostic Radiopharmaceuticals & Contrast Media, Industry Ranking, 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of Diagnostic Radiopharmaceuticals & Contrast Media, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Diagnostic Radiopharmaceuticals & Contrast Media, Product Type & Application

2.7 Global Key Manufacturers of Diagnostic Radiopharmaceuticals & Contrast Media, Date of Enter into This Industry

2.8 Global Diagnostic Radiopharmaceuticals & Contrast Media Market Competitive Situation and Trends

2.8.1 Global Diagnostic Radiopharmaceuticals & Contrast Media Market Concentration Rate

2.8.2 The Global 5 and 10 Largest Diagnostic Radiopharmaceuticals & Contrast Media Players Market Share by Revenue

2.8.3 Global Diagnostic Radiopharmaceuticals & Contrast Media Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

2.9 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Global Diagnostic Radiopharmaceuticals & Contrast Media Market Scenario by Region

3.1 Global Diagnostic Radiopharmaceuticals & Contrast Media Market Size by Region: 2020 Versus 2024 Versus 2031

3.2 Global Diagnostic Radiopharmaceuticals & Contrast Media Sales by Region: 2020-2031

3.2.1 Global Diagnostic Radiopharmaceuticals & Contrast Media Sales by Region: 2020-2025

3.2.2 Global Diagnostic Radiopharmaceuticals & Contrast Media Sales by Region: 2026-2031

3.3 Global Diagnostic Radiopharmaceuticals & Contrast Media Revenue by Region: 2020-2031

3.3.1 Global Diagnostic Radiopharmaceuticals & Contrast Media Revenue by Region: 2020-2025

3.3.2 Global Diagnostic Radiopharmaceuticals & Contrast Media Revenue by Region: 2026-2031

3.4 North America Diagnostic Radiopharmaceuticals & Contrast Media Market Facts & Figures by Country

3.4.1 North America Diagnostic Radiopharmaceuticals & Contrast Media Market Size by Country: 2020 VS 2024 VS 2031

3.4.2 North America Diagnostic Radiopharmaceuticals & Contrast Media Sales by Country (2020-2031)

3.4.3 North America Diagnostic Radiopharmaceuticals & Contrast Media Revenue by Country (2020-2031)

3.4.4 U.S.

3.4.5 Canada

3.5 Europe Diagnostic Radiopharmaceuticals & Contrast Media Market Facts & Figures by Country

3.5.1 Europe Diagnostic Radiopharmaceuticals & Contrast Media Market Size by Country: 2020 VS 2024 VS 2031

3.5.2 Europe Diagnostic Radiopharmaceuticals & Contrast Media Sales by Country (2020-2031)

3.5.3 Europe Diagnostic Radiopharmaceuticals & Contrast Media Revenue by Country (2020-2031)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Diagnostic Radiopharmaceuticals & Contrast Media Market Facts & Figures by Region

3.6.1 Asia Pacific Diagnostic Radiopharmaceuticals & Contrast Media Market Size by Region: 2020 VS 2024 VS 2031

3.6.2 Asia Pacific Diagnostic Radiopharmaceuticals & Contrast Media Sales by Region (2020-2031)

3.6.3 Asia Pacific Diagnostic Radiopharmaceuticals & Contrast Media Revenue by Region (2020-2031)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 Taiwan

3.6.10 Indonesia

3.6.11 Thailand

3.6.12 Malaysia

3.6.13 Philippines

3.7 Latin America Diagnostic Radiopharmaceuticals & Contrast Media Market Facts & Figures by Country

3.7.1 Latin America Diagnostic Radiopharmaceuticals & Contrast Media Market Size by Country: 2020 VS 2024 VS 2031

3.7.2 Latin America Diagnostic Radiopharmaceuticals & Contrast Media Sales by Country (2020-2031)

3.7.3 Latin America Diagnostic Radiopharmaceuticals & Contrast Media Revenue by Country (2020-2031)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa Diagnostic Radiopharmaceuticals & Contrast Media Market Facts & Figures by Country

3.8.1 Middle East and Africa Diagnostic Radiopharmaceuticals & Contrast Media Market Size by Country: 2020 VS 2024 VS 2031

3.8.2 Middle East and Africa Diagnostic Radiopharmaceuticals & Contrast Media Sales by Country (2020-2031)

3.8.3 Middle East and Africa Diagnostic Radiopharmaceuticals & Contrast Media Revenue by Country (2020-2031)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4 Segment by Type

4.1 Global Diagnostic Radiopharmaceuticals & Contrast Media Sales by Type (2020-2031)

4.1.1 Global Diagnostic Radiopharmaceuticals & Contrast Media Sales by Type (2020-2025)

4.1.2 Global Diagnostic Radiopharmaceuticals & Contrast Media Sales by Type (2026-2031)

4.1.3 Global Diagnostic Radiopharmaceuticals & Contrast Media Sales Market Share by Type (2020-2031)

4.2 Global Diagnostic Radiopharmaceuticals & Contrast Media Revenue by Type (2020-2031)

4.2.1 Global Diagnostic Radiopharmaceuticals & Contrast Media Revenue by Type (2020-2025)

4.2.2 Global Diagnostic Radiopharmaceuticals & Contrast Media Revenue by Type (2026-2031)

4.2.3 Global Diagnostic Radiopharmaceuticals & Contrast Media Revenue Market Share by Type (2020-2031)

4.3 Global Diagnostic Radiopharmaceuticals & Contrast Media Price by Type (2020-2031)

5 Segment by Application

5.1 Global Diagnostic Radiopharmaceuticals & Contrast Media Sales by Application (2020-2031)

5.1.1 Global Diagnostic Radiopharmaceuticals & Contrast Media Sales by Application (2020-2025)

5.1.2 Global Diagnostic Radiopharmaceuticals & Contrast Media Sales by Application (2026-2031)

5.1.3 Global Diagnostic Radiopharmaceuticals & Contrast Media Sales Market Share by Application (2020-2031)

5.2 Global Diagnostic Radiopharmaceuticals & Contrast Media Revenue by Application (2020-2031)

5.2.1 Global Diagnostic Radiopharmaceuticals & Contrast Media Revenue by Application (2020-2025)

5.2.2 Global Diagnostic Radiopharmaceuticals & Contrast Media Revenue by Application (2026-2031)

5.2.3 Global Diagnostic Radiopharmaceuticals & Contrast Media Revenue Market Share by Application (2020-2031)

5.3 Global Diagnostic Radiopharmaceuticals & Contrast Media Price by Application (2020-2031)

6 Key Companies Profiled

6.1 Amag Pharmaceuticals

6.1.1 Amag Pharmaceuticals Company Information

6.1.2 Amag Pharmaceuticals Description and Business Overview

6.1.3 Amag Pharmaceuticals Diagnostic Radiopharmaceuticals & Contrast Media Sales, Revenue and Gross Margin (2020-2025)

6.1.4 Amag Pharmaceuticals Diagnostic Radiopharmaceuticals & Contrast Media Product Portfolio

6.1.5 Amag Pharmaceuticals Recent Developments/Updates

6.2 Bayer Healthcare

6.2.1 Bayer Healthcare Company Information

6.2.2 Bayer Healthcare Description and Business Overview

6.2.3 Bayer Healthcare Diagnostic Radiopharmaceuticals & Contrast Media Sales, Revenue and Gross Margin (2020-2025)

6.2.4 Bayer Healthcare Diagnostic Radiopharmaceuticals & Contrast Media Product Portfolio

6.2.5 Bayer Healthcare Recent Developments/Updates

6.3 Bracco Imaging

6.3.1 Bracco Imaging Company Information

6.3.2 Bracco Imaging Description and Business Overview

6.3.3 Bracco Imaging Diagnostic Radiopharmaceuticals & Contrast Media Sales, Revenue and Gross Margin (2020-2025)

6.3.4 Bracco Imaging Diagnostic Radiopharmaceuticals & Contrast Media Product Portfolio

6.3.5 Bracco Imaging Recent Developments/Updates

6.4 Daiichi Sankyo

6.4.1 Daiichi Sankyo Company Information

6.4.2 Daiichi Sankyo Description and Business Overview

6.4.3 Daiichi Sankyo Diagnostic Radiopharmaceuticals & Contrast Media Sales, Revenue and Gross Margin (2020-2025)

6.4.4 Daiichi Sankyo Diagnostic Radiopharmaceuticals & Contrast Media Product Portfolio

6.4.5 Daiichi Sankyo Recent Developments/Updates

6.5 GE Healthcare

6.5.1 GE Healthcare Company Information

6.5.2 GE Healthcare Description and Business Overview

6.5.3 GE Healthcare Diagnostic Radiopharmaceuticals & Contrast Media Sales, Revenue and Gross Margin (2020-2025)

6.5.4 GE Healthcare Diagnostic Radiopharmaceuticals & Contrast Media Product Portfolio

6.5.5 GE Healthcare Recent Developments/Updates

6.6 Guerbet

6.6.1 Guerbet Company Information

6.6.2 Guerbet Description and Business Overview

6.6.3 Guerbet Diagnostic Radiopharmaceuticals & Contrast Media Sales, Revenue and Gross Margin (2020-2025)

6.6.4 Guerbet Diagnostic Radiopharmaceuticals & Contrast Media Product Portfolio

6.6.5 Guerbet Recent Developments/Updates

6.7 Lantheus

6.7.1 Lantheus Company Information

6.7.2 Lantheus Description and Business Overview

6.7.3 Lantheus Diagnostic Radiopharmaceuticals & Contrast Media Sales, Revenue and Gross Margin (2020-2025)

6.7.4 Lantheus Diagnostic Radiopharmaceuticals & Contrast Media Product Portfolio

6.7.5 Lantheus Recent Developments/Updates

6.8 Mallinckrodt

6.8.1 Mallinckrodt Company Information

6.8.2 Mallinckrodt Description and Business Overview

6.8.3 Mallinckrodt Diagnostic Radiopharmaceuticals & Contrast Media Sales, Revenue and Gross Margin (2020-2025)

6.8.4 Mallinckrodt Diagnostic Radiopharmaceuticals & Contrast Media Product Portfolio

6.8.5 Mallinckrodt Recent Developments/Updates

6.9 Medtronic

6.9.1 Medtronic Company Information

6.9.2 Medtronic Description and Business Overview

6.9.3 Medtronic Diagnostic Radiopharmaceuticals & Contrast Media Sales, Revenue and Gross Margin (2020-2025)

6.9.4 Medtronic Diagnostic Radiopharmaceuticals & Contrast Media Product Portfolio

6.9.5 Medtronic Recent Developments/Updates

6.10 Nordion

6.10.1 Nordion Company Information

6.10.2 Nordion Description and Business Overview

6.10.3 Nordion Diagnostic Radiopharmaceuticals & Contrast Media Sales, Revenue and Gross Margin (2020-2025)

6.10.4 Nordion Diagnostic Radiopharmaceuticals & Contrast Media Product Portfolio

6.10.5 Nordion Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Diagnostic Radiopharmaceuticals & Contrast Media Industry Chain Analysis

7.2 Diagnostic Radiopharmaceuticals & Contrast Media Raw Material Supply Analysis

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Diagnostic Radiopharmaceuticals & Contrast Media Production Mode & Process Analysis

7.4 Diagnostic Radiopharmaceuticals & Contrast Media Sales and Marketing

7.4.1 Diagnostic Radiopharmaceuticals & Contrast Media Sales Channels

7.4.2 Diagnostic Radiopharmaceuticals & Contrast Media Distributors

7.5 Diagnostic Radiopharmaceuticals & Contrast Media Customer Analysis

8 Diagnostic Radiopharmaceuticals & Contrast Media Market Dynamics

8.1 Diagnostic Radiopharmaceuticals & Contrast Media Industry Trends

8.2 Diagnostic Radiopharmaceuticals & Contrast Media Market Drivers

8.3 Diagnostic Radiopharmaceuticals & Contrast Media Market Challenges

8.4 Diagnostic Radiopharmaceuticals & Contrast Media Market Restraints

9 Research Findings and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

List of Tables

Table 1. Global Diagnostic Radiopharmaceuticals & Contrast Media Market Value Comparison by Type (2024 VS 2031) & (US$ Million)

Table 2. Global Diagnostic Radiopharmaceuticals & Contrast Media Market Value by Application (2024 VS 2031) & (US$ Million)

Table 3. Global Diagnostic Radiopharmaceuticals & Contrast Media Market Competitive Situation by Manufacturers in 2024

Table 4. Global Diagnostic Radiopharmaceuticals & Contrast Media Sales (K Units) of Key Manufacturers (2020-2025)

Table 5. Global Diagnostic Radiopharmaceuticals & Contrast Media Sales Market Share by Manufacturers (2020-2025)

Table 6. Global Diagnostic Radiopharmaceuticals & Contrast Media Revenue (US$ Million) by Manufacturers (2020-2025)

Table 7. Global Diagnostic Radiopharmaceuticals & Contrast Media Revenue Share by Manufacturers (2020-2025)

Table 8. Global Market Diagnostic Radiopharmaceuticals & Contrast Media Average Price (USD/Unit) of Key Manufacturers (2020-2025)

Table 9. Global Key Players of Diagnostic Radiopharmaceuticals & Contrast Media, Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of Diagnostic Radiopharmaceuticals & Contrast Media, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of Diagnostic Radiopharmaceuticals & Contrast Media, Product Type & Application

Table 12. Global Key Manufacturers of Diagnostic Radiopharmaceuticals & Contrast Media, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Diagnostic Radiopharmaceuticals & Contrast Media by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Diagnostic Radiopharmaceuticals & Contrast Media as of 2024)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Diagnostic Radiopharmaceuticals & Contrast Media Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 17. Global Diagnostic Radiopharmaceuticals & Contrast Media Sales by Region (2020-2025) & (K Units)

Table 18. Global Diagnostic Radiopharmaceuticals & Contrast Media Sales Market Share by Region (2020-2025)

Table 19. Global Diagnostic Radiopharmaceuticals & Contrast Media Sales by Region (2026-2031) & (K Units)

Table 20. Global Diagnostic Radiopharmaceuticals & Contrast Media Sales Market Share by Region (2026-2031)

Table 21. Global Diagnostic Radiopharmaceuticals & Contrast Media Revenue by Region (2020-2025) & (US$ Million)

Table 22. Global Diagnostic Radiopharmaceuticals & Contrast Media Revenue Market Share by Region (2020-2025)

Table 23. Global Diagnostic Radiopharmaceuticals & Contrast Media Revenue by Region (2026-2031) & (US$ Million)

Table 24. Global Diagnostic Radiopharmaceuticals & Contrast Media Revenue Market Share by Region (2026-2031)

Table 25. North America Diagnostic Radiopharmaceuticals & Contrast Media Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 26. North America Diagnostic Radiopharmaceuticals & Contrast Media Sales by Country (2020-2025) & (K Units)

Table 27. North America Diagnostic Radiopharmaceuticals & Contrast Media Sales by Country (2026-2031) & (K Units)

Table 28. North America Diagnostic Radiopharmaceuticals & Contrast Media Revenue by Country (2020-2025) & (US$ Million)

Table 29. North America Diagnostic Radiopharmaceuticals & Contrast Media Revenue by Country (2026-2031) & (US$ Million)

Table 30. Europe Diagnostic Radiopharmaceuticals & Contrast Media Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 31. Europe Diagnostic Radiopharmaceuticals & Contrast Media Sales by Country (2020-2025) & (K Units)

Table 32. Europe Diagnostic Radiopharmaceuticals & Contrast Media Sales by Country (2026-2031) & (K Units)

Table 33. Europe Diagnostic Radiopharmaceuticals & Contrast Media Revenue by Country (2020-2025) & (US$ Million)

Table 34. Europe Diagnostic Radiopharmaceuticals & Contrast Media Revenue by Country (2026-2031) & (US$ Million)

Table 35. Asia Pacific Diagnostic Radiopharmaceuticals & Contrast Media Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 36. Asia Pacific Diagnostic Radiopharmaceuticals & Contrast Media Sales by Region (2020-2025) & (K Units)

Table 37. Asia Pacific Diagnostic Radiopharmaceuticals & Contrast Media Sales by Region (2026-2031) & (K Units)

Table 38. Asia Pacific Diagnostic Radiopharmaceuticals & Contrast Media Revenue by Region (2020-2025) & (US$ Million)

Table 39. Asia Pacific Diagnostic Radiopharmaceuticals & Contrast Media Revenue by Region (2026-2031) & (US$ Million)

Table 40. Latin America Diagnostic Radiopharmaceuticals & Contrast Media Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 41. Latin America Diagnostic Radiopharmaceuticals & Contrast Media Sales by Country (2020-2025) & (K Units)

Table 42. Latin America Diagnostic Radiopharmaceuticals & Contrast Media Sales by Country (2026-2031) & (K Units)

Table 43. Latin America Diagnostic Radiopharmaceuticals & Contrast Media Revenue by Country (2020-2025) & (US$ Million)

Table 44. Latin America Diagnostic Radiopharmaceuticals & Contrast Media Revenue by Country (2026-2031) & (US$ Million)

Table 45. Middle East and Africa Diagnostic Radiopharmaceuticals & Contrast Media Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 46. Middle East and Africa Diagnostic Radiopharmaceuticals & Contrast Media Sales by Country (2020-2025) & (K Units)

Table 47. Middle East and Africa Diagnostic Radiopharmaceuticals & Contrast Media Sales by Country (2026-2031) & (K Units)

Table 48. Middle East and Africa Diagnostic Radiopharmaceuticals & Contrast Media Revenue by Country (2020-2025) & (US$ Million)

Table 49. Middle East and Africa Diagnostic Radiopharmaceuticals & Contrast Media Revenue by Country (2026-2031) & (US$ Million)

Table 50. Global Diagnostic Radiopharmaceuticals & Contrast Media Sales (K Units) by Type (2020-2025)

Table 51. Global Diagnostic Radiopharmaceuticals & Contrast Media Sales (K Units) by Type (2026-2031)

Table 52. Global Diagnostic Radiopharmaceuticals & Contrast Media Sales Market Share by Type (2020-2025)

Table 53. Global Diagnostic Radiopharmaceuticals & Contrast Media Sales Market Share by Type (2026-2031)

Table 54. Global Diagnostic Radiopharmaceuticals & Contrast Media Revenue (US$ Million) by Type (2020-2025)

Table 55. Global Diagnostic Radiopharmaceuticals & Contrast Media Revenue (US$ Million) by Type (2026-2031)

Table 56. Global Diagnostic Radiopharmaceuticals & Contrast Media Revenue Market Share by Type (2020-2025)

Table 57. Global Diagnostic Radiopharmaceuticals & Contrast Media Revenue Market Share by Type (2026-2031)

Table 58. Global Diagnostic Radiopharmaceuticals & Contrast Media Price (USD/Unit) by Type (2020-2025)

Table 59. Global Diagnostic Radiopharmaceuticals & Contrast Media Price (USD/Unit) by Type (2026-2031)

Table 60. Global Diagnostic Radiopharmaceuticals & Contrast Media Sales (K Units) by Application (2020-2025)

Table 61. Global Diagnostic Radiopharmaceuticals & Contrast Media Sales (K Units) by Application (2026-2031)

Table 62. Global Diagnostic Radiopharmaceuticals & Contrast Media Sales Market Share by Application (2020-2025)

Table 63. Global Diagnostic Radiopharmaceuticals & Contrast Media Sales Market Share by Application (2026-2031)

Table 64. Global Diagnostic Radiopharmaceuticals & Contrast Media Revenue (US$ Million) by Application (2020-2025)

Table 65. Global Diagnostic Radiopharmaceuticals & Contrast Media Revenue (US$ Million) by Application (2026-2031)

Table 66. Global Diagnostic Radiopharmaceuticals & Contrast Media Revenue Market Share by Application (2020-2025)

Table 67. Global Diagnostic Radiopharmaceuticals & Contrast Media Revenue Market Share by Application (2026-2031)

Table 68. Global Diagnostic Radiopharmaceuticals & Contrast Media Price (USD/Unit) by Application (2020-2025)

Table 69. Global Diagnostic Radiopharmaceuticals & Contrast Media Price (USD/Unit) by Application (2026-2031)

Table 70. Amag Pharmaceuticals Company Information

Table 71. Amag Pharmaceuticals Description and Business Overview

Table 72. Amag Pharmaceuticals Diagnostic Radiopharmaceuticals & Contrast Media Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 73. Amag Pharmaceuticals Diagnostic Radiopharmaceuticals & Contrast Media Product

Table 74. Amag Pharmaceuticals Recent Developments/Updates

Table 75. Bayer Healthcare Company Information

Table 76. Bayer Healthcare Description and Business Overview

Table 77. Bayer Healthcare Diagnostic Radiopharmaceuticals & Contrast Media Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 78. Bayer Healthcare Diagnostic Radiopharmaceuticals & Contrast Media Product

Table 79. Bayer Healthcare Recent Developments/Updates

Table 80. Bracco Imaging Company Information

Table 81. Bracco Imaging Description and Business Overview

Table 82. Bracco Imaging Diagnostic Radiopharmaceuticals & Contrast Media Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 83. Bracco Imaging Diagnostic Radiopharmaceuticals & Contrast Media Product

Table 84. Bracco Imaging Recent Developments/Updates

Table 85. Daiichi Sankyo Company Information

Table 86. Daiichi Sankyo Description and Business Overview

Table 87. Daiichi Sankyo Diagnostic Radiopharmaceuticals & Contrast Media Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 88. Daiichi Sankyo Diagnostic Radiopharmaceuticals & Contrast Media Product

Table 89. Daiichi Sankyo Recent Developments/Updates

Table 90. GE Healthcare Company Information

Table 91. GE Healthcare Description and Business Overview

Table 92. GE Healthcare Diagnostic Radiopharmaceuticals & Contrast Media Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 93. GE Healthcare Diagnostic Radiopharmaceuticals & Contrast Media Product

Table 94. GE Healthcare Recent Developments/Updates

Table 95. Guerbet Company Information

Table 96. Guerbet Description and Business Overview

Table 97. Guerbet Diagnostic Radiopharmaceuticals & Contrast Media Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 98. Guerbet Diagnostic Radiopharmaceuticals & Contrast Media Product

Table 99. Guerbet Recent Developments/Updates

Table 100. Lantheus Company Information

Table 101. Lantheus Description and Business Overview

Table 102. Lantheus Diagnostic Radiopharmaceuticals & Contrast Media Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 103. Lantheus Diagnostic Radiopharmaceuticals & Contrast Media Product

Table 104. Lantheus Recent Developments/Updates

Table 105. Mallinckrodt Company Information

Table 106. Mallinckrodt Description and Business Overview

Table 107. Mallinckrodt Diagnostic Radiopharmaceuticals & Contrast Media Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 108. Mallinckrodt Diagnostic Radiopharmaceuticals & Contrast Media Product

Table 109. Mallinckrodt Recent Developments/Updates

Table 110. Medtronic Company Information

Table 111. Medtronic Description and Business Overview

Table 112. Medtronic Diagnostic Radiopharmaceuticals & Contrast Media Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 113. Medtronic Diagnostic Radiopharmaceuticals & Contrast Media Product

Table 114. Medtronic Recent Developments/Updates

Table 115. Nordion Company Information

Table 116. Nordion Description and Business Overview

Table 117. Nordion Diagnostic Radiopharmaceuticals & Contrast Media Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 118. Nordion Diagnostic Radiopharmaceuticals & Contrast Media Product

Table 119. Nordion Recent Developments/Updates

Table 120. Key Raw Materials Lists

Table 121. Raw Materials Key Suppliers Lists

Table 122. Diagnostic Radiopharmaceuticals & Contrast Media Distributors List

Table 123. Diagnostic Radiopharmaceuticals & Contrast Media Customers List

Table 124. Diagnostic Radiopharmaceuticals & Contrast Media Market Trends

Table 125. Diagnostic Radiopharmaceuticals & Contrast Media Market Drivers

Table 126. Diagnostic Radiopharmaceuticals & Contrast Media Market Challenges

Table 127. Diagnostic Radiopharmaceuticals & Contrast Media Market Restraints

Table 128. Research Programs/Design for This Report

Table 129. Key Data Information from Secondary Sources

Table 130. Key Data Information from Primary Sources

Table 131. Authors List of This Report

List of Figures

Figure 1. Product Picture of Diagnostic Radiopharmaceuticals & Contrast Media

Figure 2. Global Diagnostic Radiopharmaceuticals & Contrast Media Market Value Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Diagnostic Radiopharmaceuticals & Contrast Media Market Share by Type: 2024 & 2031

Figure 4. Radiopharmaceuticals Product Picture

Figure 5. Contrast Media Product Picture

Figure 6. Global Diagnostic Radiopharmaceuticals & Contrast Media Market Value by Application (2020-2031) & (US$ Million)

Figure 7. Global Diagnostic Radiopharmaceuticals & Contrast Media Market Share by Application: 2024 & 2031

Figure 8. Hospital

Figure 9. Clinic

Figure 10. Other

Figure 11. Global Diagnostic Radiopharmaceuticals & Contrast Media Revenue, (US$ Million), 2020 VS 2024 VS 2031

Figure 12. Global Diagnostic Radiopharmaceuticals & Contrast Media Market Size (2020-2031) & (US$ Million)

Figure 13. Global Diagnostic Radiopharmaceuticals & Contrast Media Sales (2020-2031) & (K Units)

Figure 14. Global Diagnostic Radiopharmaceuticals & Contrast Media Average Price (USD/Unit) & (2020-2031)

Figure 15. Diagnostic Radiopharmaceuticals & Contrast Media Report Years Considered

Figure 16. Diagnostic Radiopharmaceuticals & Contrast Media Sales Share by Manufacturers in 2024

Figure 17. Global Diagnostic Radiopharmaceuticals & Contrast Media Revenue Share by Manufacturers in 2024

Figure 18. Global 5 and 10 Largest Diagnostic Radiopharmaceuticals & Contrast Media Players: Market Share by Revenue in Diagnostic Radiopharmaceuticals & Contrast Media in 2024

Figure 19. Diagnostic Radiopharmaceuticals & Contrast Media Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 20. Global Diagnostic Radiopharmaceuticals & Contrast Media Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Figure 21. North America Diagnostic Radiopharmaceuticals & Contrast Media Sales Market Share by Country (2020-2031)

Figure 22. North America Diagnostic Radiopharmaceuticals & Contrast Media Revenue Market Share by Country (2020-2031)

Figure 23. U.S. Diagnostic Radiopharmaceuticals & Contrast Media Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 24. Canada Diagnostic Radiopharmaceuticals & Contrast Media Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 25. Europe Diagnostic Radiopharmaceuticals & Contrast Media Sales Market Share by Country (2020-2031)

Figure 26. Europe Diagnostic Radiopharmaceuticals & Contrast Media Revenue Market Share by Country (2020-2031)

Figure 27. Germany Diagnostic Radiopharmaceuticals & Contrast Media Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 28. France Diagnostic Radiopharmaceuticals & Contrast Media Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 29. U.K. Diagnostic Radiopharmaceuticals & Contrast Media Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 30. Italy Diagnostic Radiopharmaceuticals & Contrast Media Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 31. Russia Diagnostic Radiopharmaceuticals & Contrast Media Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 32. Asia Pacific Diagnostic Radiopharmaceuticals & Contrast Media Sales Market Share by Region (2020-2031)

Figure 33. Asia Pacific Diagnostic Radiopharmaceuticals & Contrast Media Revenue Market Share by Region (2020-2031)

Figure 34. China Diagnostic Radiopharmaceuticals & Contrast Media Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 35. Japan Diagnostic Radiopharmaceuticals & Contrast Media Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 36. South Korea Diagnostic Radiopharmaceuticals & Contrast Media Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 37. India Diagnostic Radiopharmaceuticals & Contrast Media Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 38. Australia Diagnostic Radiopharmaceuticals & Contrast Media Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 39. Taiwan Diagnostic Radiopharmaceuticals & Contrast Media Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 40. Indonesia Diagnostic Radiopharmaceuticals & Contrast Media Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 41. Thailand Diagnostic Radiopharmaceuticals & Contrast Media Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 42. Malaysia Diagnostic Radiopharmaceuticals & Contrast Media Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 43. Philippines Diagnostic Radiopharmaceuticals & Contrast Media Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 44. Latin America Diagnostic Radiopharmaceuticals & Contrast Media Sales Market Share by Country (2020-2031)

Figure 45. Latin America Diagnostic Radiopharmaceuticals & Contrast Media Revenue Market Share by Country (2020-2031)

Figure 46. Mexico Diagnostic Radiopharmaceuticals & Contrast Media Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 47. Brazil Diagnostic Radiopharmaceuticals & Contrast Media Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 48. Argentina Diagnostic Radiopharmaceuticals & Contrast Media Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 49. Middle East and Africa Diagnostic Radiopharmaceuticals & Contrast Media Sales Market Share by Country (2020-2031)

Figure 50. Middle East and Africa Diagnostic Radiopharmaceuticals & Contrast Media Revenue Market Share by Country (2020-2031)

Figure 51. Turkey Diagnostic Radiopharmaceuticals & Contrast Media Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 52. Saudi Arabia Diagnostic Radiopharmaceuticals & Contrast Media Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 53. UAE Diagnostic Radiopharmaceuticals & Contrast Media Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 54. Global Sales Market Share of Diagnostic Radiopharmaceuticals & Contrast Media by Type (2020-2031)

Figure 55. Global Revenue Market Share of Diagnostic Radiopharmaceuticals & Contrast Media by Type (2020-2031)

Figure 56. Global Diagnostic Radiopharmaceuticals & Contrast Media Price (USD/Unit) by Type (2020-2031)

Figure 57. Global Sales Market Share of Diagnostic Radiopharmaceuticals & Contrast Media by Application (2020-2031)

Figure 58. Global Revenue Market Share of Diagnostic Radiopharmaceuticals & Contrast Media by Application (2020-2031)

Figure 59. Global Diagnostic Radiopharmaceuticals & Contrast Media Price (USD/Unit) by Application (2020-2031)

Figure 60. Diagnostic Radiopharmaceuticals & Contrast Media Value Chain

Figure 61. Channels of Distribution (Direct Vs Distribution)

Figure 62. Bottom-up and Top-down Approaches for This Report

Figure 63. Data Triangulation

Figure 64. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

120 Pages

Type: Report

Code: QYRE-Auto-0P17200

Mon Nov 10 00:00:00 UTC 2025

Add to Cart

Global Suvorexant API Market Outlook, In‑Depth Analysis & Forecast to 2031

120 Pages

Type: Report

Code: QYRE-Auto-35S16715

Fri Nov 07 00:00:00 UTC 2025

Add to Cart

Global Norfloxacin Eye Drops Market Outlook, In‑Depth Analysis & Forecast to 2031

120 Pages

Type: Report

Code: QYRE-Auto-35J16932

Fri Nov 07 00:00:00 UTC 2025

Add to Cart

Global Calcobutrol Market Outlook, In‑Depth Analysis & Forecast to 2031

120 Pages

Type: Report

Code: QYRE-Auto-4M17172

Fri Nov 07 00:00:00 UTC 2025

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions

Global Diagnostic Radiopharmaceuticals & Contrast Media Market Research Report 2025

Published Date: August 2025

Report Code: QYRE-Auto-30L2144

Global Diagnostic Radiopharmaceuticals & Contrast Media Market Research Report 2025

FEATURED COMPANIES

Diagnostic Radiopharmaceuticals & Contrast Media Market Size

Diagnostic Radiopharmaceuticals & Contrast Media Market

Report Scope

Scope of Diagnostic Radiopharmaceuticals & Contrast Media Market Report

Core Chapters

FAQ for this report

How fast is Diagnostic Radiopharmaceuticals & Contrast Media Market growing?

What is the Diagnostic Radiopharmaceuticals & Contrast Media Market size in 2031?

Who are the main players in the Diagnostic Radiopharmaceuticals & Contrast Media Market report?

What are the Application segmentation covered in the Diagnostic Radiopharmaceuticals & Contrast Media Market report?

What are the Type segmentation covered in the Diagnostic Radiopharmaceuticals & Contrast Media Market report?

FEATURED COMPANIES

RELATED REPORTS